跳至主要内容
临床试验/NCT00491309
NCT00491309Unknown不适用

Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary Hypertension

Heidelberg University2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2011年7月最近更新:
适应症

试验速览

阶段
不适用
入组人数
45
试验地点
2
主要终点
Quality of life (SF-36)

研究概览

简要总结

In Patients with rheumatic disease exercise training is a well established element of therapy. In contrast patients with severe pulmonary hypertension are advised to avoid physical exertion and must not perform exercise training. This study aims to evaluate the effectivity and safety of a low-dose training program in patients with pulmonary hypertension and rheumatic disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent
  • Men and women 18 - 80 years
  • Diagnosed rheumatic disease: rheumatoid arthritis, Collagenosis (Systemic Lupus Erythematodes, Systemic Sclerosis, Sjögren-Syndrome, Sharp-Syndrome, Crest-Syndrome, Mixed connective tissue disease)
  • Symptomatic PAH (WHO- functional class II-IV) invasively diagnosed by right heart catheterisation
  • Mean pulmonary artery pressure (mPAP) > 25 mmHg
  • Pulmonary capillary wedge pressure (PCWP) > 15 mmHg
  • Pulmonary vascular resistance (PVR) at baseline >320 dyn.sec/cm5 patients under optimized medical treatment since at least 2 ½ months

排除标准

  • Other forms of PAH.
  • Pregnancy or lactation
  • Change in medication during the last 2 ½ months
  • Patients with signs of right heart decompensation
  • Severe impairment of walking
  • Unclear diagnosis
  • No invasive diagnosis of PH
  • Acute illness, infection, fever
  • Severe lung disease with FEV1 <50% and TLC< 70% below reference

结局指标

主要结局

Quality of life (SF-36)

时间窗: baseline and 15 weeks

Change in the 6-minute walking distance

时间窗: after 3 weeks and after 15 weeks compared to baseline.

次要结局

  • Physical capacity in the cardiopulmonary exercise testing (Watt)(baseline, 3 weeks, 15 weeks)
  • change of peak oxygen consumption and other parameters of cardiopulmonary exercise testing.(baseline, 3 weeks, 15 weeks)
  • hemodynamic parameters: dimension and pump function of the right and the left ventricle.(baseline, 15 weeks)
  • change in systolic pulmonary arterial pressure at rest and during exercise(baseline, 3 weeks, 15 weeks)
  • change in inflammatory parameters (BKS, CRP, Leucocytes), change in inflammatory cytokines (TNF-α), change in parameters of the vascular endothelium (Endothelin, PDGF, VEGF), and endothelial progenitor cells(baseline and 15 weeks)
  • change of NTproBNP-value(baseline, 3 weeks, 15 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. med. Ekkehard Gruenig

Prof. Dr. med. Ekkehard Grünig

Heidelberg University

研究点 (2)

Loading locations...

相似试验